Its not comparable to prescription GLP-1 medications in terms of effectiveness or regulatory oversight
doi: 10.1016/j.molmet.2018.09.009 21 SkowMABergmannNCKnopFK
GLP-1RAs, including liraglutide, have been shown in animal models to reduce ICP by inhibiting the activity in the choroid plexus of an enzyme called the sodium-potassium pump
One of those researchers is Georgia State University Professor of Neuroscience and Georgia Research Alliance Distinguished Investigator Eric Krause
It confirmed what we were seeing clinically that stopping without a structured plan puts most patients at significant risk of regaining the majority of what they worked to lose
Many tirzepatide tablets sold online are unapproved products, and the FDA has publicly warned about safety, quality, counterfeit labeling, and dosing problems with unapproved GLP-1 drugs marketed for weight loss (FDA warning on unapproved GLP-1 drugs)